The evolving need for patient reported outcome data in determining choice of immune therapy treatment

Research output: Contribution to journalArticlepeer-review

Abstract

Cellular therapy has changed the cancer treatment landscape and potential associated toxicities. The traditional short-term toxicities of chemotherapy-induced nausea, vomiting, and diarrhea are replaced by complex immune activation syndromes and immunologic organ-specific toxicities. Understanding the long-term consequences and impact of these therapies on patient quality of life is necessary.

Original languageEnglish (US)
Pages (from-to)907-911
Number of pages5
JournalMed
Volume2
Issue number8
DOIs
StatePublished - Aug 13 2021
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'The evolving need for patient reported outcome data in determining choice of immune therapy treatment'. Together they form a unique fingerprint.

Cite this